This may be the shock to the system that will make business leaders realize that diversity is not an accessory or PR stunt — it is an integral part of the daily lives of each and every member of your team. People from minority backgrounds tend to have less robust business networks, exactly because they are the minority in the business world. As a business leader you can always be seeking out diverse founders to collaborate with; For example, check out this amazing list of Latinx founders catering to the United States’ enormous Latinx markets, as well as finding solutions to improve diversity in business.
And among the shares rising the most are today’s two venture-backed IPOs: Lemonade and Accolade. TechCrunch wrote this morning that the firms’ aggressive IPO pricing arcs boded well for the IPO market itself, that investors were willing to price growth-y shares of unprofitable companies with vigor, which could help other companies looking at the public markets get off the sidelines. Lemonade: $61.62 per share, up $32.62 or 112.48% Accolade: $34.39 per share, up $12.39 or 56.32%
Fast forward to 2020 and you’ll see that modern software pipelines face a similar “Great Stink” due, in no small part, to the vast adoption of continuous integration (CI), the practice of merging all developers’ working copies into a shared mainline several times a day, and continuous delivery (CD), the ability to get changes of all types — including new features, configuration changes, bug fixes and experiments — into production, or into the hands of users, safely and quickly in a sustainable way. While contemporary software failures won’t spread disease or emit the rancid smells of the past, they certainly reek of devastation, rendering billions of dollars lost and millions of developer hours wasted each year. Everyone is employing CI/CD to accelerate software delivery; yet the ever-growing backlog of intermittent and sporadic test failures is doing the exact opposite.
Businesses have not only had to go through the unprecedented Covid-19 pandemic, but also various natural calamities such as cylones, wildfires and earthquakes as well as locust swarms across parts of the world and now the India-China border clashes spilling over to the business world with India’s ban on some Chinese apps. Startups are leading from the front in many key areas such as healthtech, genetic research, supply chain... Read this story on Inc42.
Jennifer Doudna, a woman whose work has triggered the explosion in innovation in the field of synthetic biology and has given researchers around the world a way to program and reprogram the living world, will be speaking at Disrupt in September. From her positions as the Chancellor’s Chair Professor in the University of California, Berkeley’s Chemistry and Molecular and Cell Biology Departments and a senior investigator at the Gladstone Institutes and professor at the University of California, San Francisco, Doudna has been at the forefront of research into CRISPR gene editing technology. Given the breadth of applications and the questions that the technology’s application raises about how and what limitations researchers should put on the technology, there will be plenty for Doudna to discuss on the Disrupt stage.
At TechCrunch Early Stage, our two-day virtual event focused on giving entrepreneurs all the resources they need to build incredible, high-growth early stage companies, we have plenty of content dedicated to the pitchdeck. From a session on how to think like a PM for VC pitch success led by Lo Toney, to a session on how to time your fundraising sprint led by Jake Saper, to seed funding tips and tricks from Jeff Clavier, there’s something for everyone. Early Stage attendees can submit their pitchdecks ahead of time for a chance to see those decks critiqued live on stage.
In fact, that’s how our relationship began — like many business leaders during this pandemic, I had to hire Todd through a series of video calls. I used to believe that you could build an in-person culture or a remote work culture, but that a hybrid of the two was destined to fail. The remote work debate changed in an instant Before the pandemic, the debate over remote work revolved around its perceived impact on productivity, collaboration, employee engagement and culture.
(Via Nasdaq webcast) Health benefits platform Accolade made its initial public offering Thursday morning, pricing its stock at $22/share, above the expected range of $19 to $21, and raising $220 million at a valuation of $1.2 billion in its debut on the Nasdaq stock market. Among the risk factors listed in its IPO filings, Accolade says its four largest corporate customers (Comcast Cable, American Airlines, Lowe’s, and State Farm) were responsible for an aggregate total of 59% of its revenue of $132.5 million for its 2020 fiscal year, which ended in February. Investors include Andreessen Horowitz, Carrick Capital Partners, Madrona Venture Group and McKesson Ventures, among others .In October, Accolade landed a $20 million investment from health insurance giant Humana as part of an ongoing partnership between the two companies.
Edtech platform upGrad, on July 1 at its quarterly town hall, announced that it has revoked all salary deductions from the second quarter of the financial year 2021, starting July. Keeping everyone’s well-being in mind we declared work from home till December 31, 2020.” upGrad was founded in early 2015 by Ronnie Screwvala, Mayank Kumar, Phalgun Kompalli and Ravijot Chugh to focus on higher education. Edtech sector has contributed to the business growth of upGrad, the company highlighted in its press note.
Many fear that India’s ban will invite retaliation and a response from China, especially impacting those companies which are currently operational in China. But it might have to bear the bulk of the consequences, being one of the most visible Indian companies in China OYO China had already laid-off thousands of employees, during the peak of COVID-19 pandemic in the country. The post India’s Ban On Chinese Apps Complicates Life For Indian Tech Companies In China appeared first on Inc42 Media.